PL409525A1 - Związek 2,3-dihydro-6-nitroimidazo[2,1-b]oksazolowy - Google Patents

Związek 2,3-dihydro-6-nitroimidazo[2,1-b]oksazolowy

Info

Publication number
PL409525A1
PL409525A1 PL409525A PL40952503A PL409525A1 PL 409525 A1 PL409525 A1 PL 409525A1 PL 409525 A PL409525 A PL 409525A PL 40952503 A PL40952503 A PL 40952503A PL 409525 A1 PL409525 A1 PL 409525A1
Authority
PL
Poland
Prior art keywords
nitroimidazo
dihydro
oxazole compound
mycobacterium tuberculosis
oxazole
Prior art date
Application number
PL409525A
Other languages
English (en)
Polish (pl)
Inventor
Hidetsugu Tsubouchi
Hirofumi Sasaki
Hideaki Kuroda
Motohiro Itotani
Takeshi Hasegawa
Yoshikazu Haraguchi
Takeshi Kuroda
Takayuki Matsuzaki
Kuninori Tai
Makoto Komatsu
Makoto Matsumoto
Hiroyuki Hashizume
Tatsuo Tomishige
Yuji Seike
Masanori Kawasaki
Takumi Sumida
Shin Miyamura
Original Assignee
Otsuka Pharmaceutical Co.,Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co.,Ltd. filed Critical Otsuka Pharmaceutical Co.,Ltd.
Publication of PL409525A1 publication Critical patent/PL409525A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL409525A 2002-10-11 2003-10-10 Związek 2,3-dihydro-6-nitroimidazo[2,1-b]oksazolowy PL409525A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002298259 2002-10-11

Publications (1)

Publication Number Publication Date
PL409525A1 true PL409525A1 (pl) 2014-11-10

Family

ID=32089299

Family Applications (3)

Application Number Title Priority Date Filing Date
PL409525A PL409525A1 (pl) 2002-10-11 2003-10-10 Związek 2,3-dihydro-6-nitroimidazo[2,1-b]oksazolowy
PL404913A PL404913A1 (pl) 2002-10-11 2003-10-10 Zwiazek 2,3-dihydro-6-nitroimidazo[2,1-b]oksazolowy
PL376157A PL217919B1 (pl) 2002-10-11 2003-10-10 Związek 2,3-dihydro-6-nitroimidazo[2,1-b]oksazolowy, kompozycja go zawierająca oraz zastosowanie

Family Applications After (2)

Application Number Title Priority Date Filing Date
PL404913A PL404913A1 (pl) 2002-10-11 2003-10-10 Zwiazek 2,3-dihydro-6-nitroimidazo[2,1-b]oksazolowy
PL376157A PL217919B1 (pl) 2002-10-11 2003-10-10 Związek 2,3-dihydro-6-nitroimidazo[2,1-b]oksazolowy, kompozycja go zawierająca oraz zastosowanie

Country Status (26)

Country Link
US (1) US7262212B2 (OSRAM)
EP (2) EP1555267B1 (OSRAM)
JP (1) JP4186065B2 (OSRAM)
KR (1) KR100723847B1 (OSRAM)
CN (4) CN100366624C (OSRAM)
AR (4) AR041198A1 (OSRAM)
AU (1) AU2003272979B2 (OSRAM)
BE (1) BE2014C053I2 (OSRAM)
BR (1) BRPI0314344B8 (OSRAM)
CA (1) CA2497569C (OSRAM)
CY (2) CY1113578T1 (OSRAM)
DK (1) DK1555267T3 (OSRAM)
ES (1) ES2400179T3 (OSRAM)
FR (1) FR14C0066I2 (OSRAM)
HU (1) HUS1400046I1 (OSRAM)
LU (1) LU92517I2 (OSRAM)
MX (1) MXPA05003674A (OSRAM)
MY (1) MY139244A (OSRAM)
PL (3) PL409525A1 (OSRAM)
PT (1) PT1555267E (OSRAM)
RU (1) RU2326121C3 (OSRAM)
SI (1) SI1555267T1 (OSRAM)
TW (1) TWI347946B (OSRAM)
UA (1) UA83200C2 (OSRAM)
WO (1) WO2004033463A1 (OSRAM)
ZA (1) ZA200501033B (OSRAM)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4564713B2 (ja) 2000-11-01 2010-10-20 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 窒素性複素環式化合物、ならびに窒素性複素環式化合物およびその中間体を作製するための方法
CA2494710C (en) * 2002-10-15 2011-05-03 Otsuka Pharmaceutical Co., Ltd. 1-substituted-4-nitroimidazole compound and method for preparing the same
RU2365593C2 (ru) 2003-10-31 2009-08-27 Оцука Фармасьютикал Ко., Лтд. ПРОИЗВОДНЫЕ 2,3-ДИГИДРО-6-НИТРОИМИДАЗО [2,1-b] ОКСАЗОЛА ДЛЯ ЛЕЧЕНИЯ ТУБЕРКУЛЕЗА
JP4761756B2 (ja) * 2003-10-31 2011-08-31 大塚製薬株式会社 ２，３−ジヒドロイミダゾ［２，１−ｂ］オキサゾ−ル化合物
TWI300409B (en) 2004-02-18 2008-09-01 Otsuka Pharma Co Ltd Method for producing 4-nitroimidazole compound
EP1731518B1 (en) 2004-03-31 2014-06-25 Nippon Soda Co., Ltd. Cyclic amine compound and pest control agent
JP4789966B2 (ja) * 2004-04-09 2011-10-12 大塚製薬株式会社 医薬組成物
JP4787529B2 (ja) * 2004-04-09 2011-10-05 大塚製薬株式会社 医薬組成物
MX2007016523A (es) * 2005-06-20 2008-03-06 Schering Corp Piperidinas sustituidas ligadas a carbono y derivados de las mismas utiles como antagonistas de hsitamina h3.
DK1906926T3 (da) * 2005-07-28 2011-01-31 Otsuka Pharma Co Ltd Farmaceutisk sammensætning omfattende 2,3-dihydro-6-nitroimidazo[2,1-b]oxazolderivater
JP5105818B2 (ja) * 2005-10-05 2012-12-26 大塚製薬株式会社 医薬組成物
TW201434467A (zh) * 2005-10-05 2014-09-16 Otsuka Pharma Co Ltd 抗結核治療藥物及含彼之套組
ES2375639T3 (es) 2005-10-06 2012-03-02 Nippon Soda Co., Ltd. Compuestos de aminas c�?clicas y agente para el control de plagas.
TW200800268A (en) * 2005-11-04 2008-01-01 Otsuka Pharma Co Ltd Medicinal composition showing improved drug absorbability
AU2006333522A1 (en) 2005-12-21 2007-07-12 Decode Genetics, Ehf. Biaryl nitrogen heterocycle inhibitors of LTA4H for treating inflammation
US20090018169A1 (en) * 2006-02-13 2009-01-15 Laboratoires Serono Sa Sulfonamide Derivatives for the Treatment of Bacterial Infections
JP2007297305A (ja) * 2006-04-28 2007-11-15 Daiso Co Ltd Ｎ−（２，３−エポキシ−２−メチルプロピル）フタルイミドの製造法
EP2125750B1 (en) * 2007-02-26 2014-05-21 Vitae Pharmaceuticals, Inc. Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1
AR070301A1 (es) * 2007-05-08 2010-03-31 Otsuka Pharma Co Ltd Compuesto epoxi y metodo para producir el mismo
JP5470557B2 (ja) * 2007-07-26 2014-04-16 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤の合成
JP2010535845A (ja) * 2007-08-15 2010-11-25 グラクソ グループ リミテッド Ｈ１受容体アンタゴニストとしての置換キノリン誘導体
WO2009050204A1 (en) * 2007-10-16 2009-04-23 Glaxo Group Limited Quinoline derivatives used to treat inflammatory and allergic diseases
AR069207A1 (es) * 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
WO2009075835A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceutical, Inc CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
TW200934490A (en) * 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
CA2712500A1 (en) 2008-01-24 2009-07-30 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5734666B2 (ja) * 2008-02-11 2015-06-17 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の１，３−オキサアゼパン−２−オン及び１，３−ジアゼパン−２−オン阻害剤
US8598160B2 (en) * 2008-02-15 2013-12-03 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
JP5538356B2 (ja) * 2008-03-18 2014-07-02 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤
CA2712613C (en) * 2008-03-26 2017-02-28 Global Alliance For Tb Drug Development Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
KR20110002492A (ko) * 2008-05-01 2011-01-07 비타이 파마슈티컬즈, 인코포레이티드 11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제
WO2009134392A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8242111B2 (en) * 2008-05-01 2012-08-14 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
CA2723034A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
KR20110050459A (ko) 2008-07-25 2011-05-13 비타이 파마슈티컬즈, 인코포레이티드 11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제
EP2324017B1 (en) 2008-07-25 2014-12-31 Boehringer Ingelheim International GmbH INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
WO2010127237A2 (en) * 2009-04-30 2010-11-04 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US9643922B2 (en) 2008-08-18 2017-05-09 Yale University MIF modulators
EA201170349A1 (ru) * 2008-08-18 2011-08-30 Йейл Юниверсити Модуляторы mif
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
EP2323990B1 (en) * 2008-08-21 2014-06-18 Dynamit Nobel GmbH Explosivstoff- und Systemtechnik Methods for the production of 2-halo-4-nitroimidazole and intermediates thereof
WO2010143007A1 (en) * 2009-06-10 2010-12-16 Dynamit Nobel Gmbh Explosivstoff-Und Systemtechnik Method for the production of 2-halogeno-4-nitroimidazole
WO2010089303A1 (en) 2009-02-04 2010-08-12 Boehringer Ingelheim International Gmbh CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1
TW201039034A (en) * 2009-04-27 2010-11-01 Chunghwa Picture Tubes Ltd Pixel structure and the method of forming the same
US8680093B2 (en) 2009-04-30 2014-03-25 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2011011123A1 (en) 2009-06-11 2011-01-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
EP2448928B1 (en) 2009-07-01 2014-08-13 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US9198913B2 (en) 2009-07-31 2015-12-01 Global Alliance For Tb Drug Development Nitroimidazooxazines and their uses in anti-tubercular therapy
EP2459570B1 (en) * 2009-07-31 2014-12-24 Global Alliance For Tb Drug Development Nitroimidazooxazine analogues and their uses
WO2011014774A1 (en) * 2009-07-31 2011-02-03 Global Alliance For Tb Drug Development Nitroimidazooxazines and their uses in anti-tubercular therapy
EP2495563A4 (en) 2009-10-26 2013-04-10 Fujifilm Ri Pharma Co Ltd DIAGNOSTIC AGENT FOR INFECTIOUS DISEASES
TW201200523A (en) 2010-01-29 2012-01-01 Otsuka Pharma Co Ltd Synthetic intermediate of oxazole compound and method for producing the same
GB201012209D0 (en) * 2010-05-31 2010-09-08 Ge Healthcare Ltd In vivo imaging agent
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
WO2011161128A1 (en) 2010-06-25 2011-12-29 Boehringer Ingelheim International Gmbh Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
AU2011325286B2 (en) 2010-11-02 2015-04-16 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of metabolic disorders
US9051333B2 (en) 2011-04-15 2015-06-09 Otsuka Pharmaceutical Co., Ltd. 6,7-dihydroimidazo [2,1-b] [1,3]oxazine bactericides
JP2015006994A (ja) * 2011-10-28 2015-01-15 大正製薬株式会社 ジヒドロイミダゾオキサゾール誘導体
US9572809B2 (en) 2012-07-18 2017-02-21 Spero Trinem, Inc. Combination therapy to treat Mycobacterium diseases
FR3000064A1 (fr) * 2012-12-21 2014-06-27 Univ Lille Ii Droit & Sante Composes de type spiroisoxazoline ayant une activite potentialisatrice de l'activite d'un antibiotique-composition et produit pharmaceutiques comprenant de tels composes
US9845330B2 (en) * 2013-10-04 2017-12-19 Council Of Scientific & Industrial Research 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles and a process for the preparation thereof
CN103524492A (zh) * 2013-10-23 2014-01-22 中国药科大学 侧链含硝基咪唑基团取代的喹诺酮类化合物、其制备及用途
TWI687409B (zh) 2014-08-28 2020-03-11 日商大塚製藥股份有限公司 稠合雜環化合物
JP6467042B2 (ja) * 2014-10-21 2019-02-06 カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ 抗マイコバクテリア剤としての置換１，２，３−トリアゾール−１−イル−メチル−２，３−ジヒドロ−２−メチル−６−ニトロイミダゾ［２，１−ｂ］オキサゾールとその調製方法
CN105732659B (zh) * 2014-12-12 2019-07-16 上海阳帆医药科技有限公司 硝基咪唑类化合物及其制备方法和在制药中的用途
JP6542900B2 (ja) * 2015-01-29 2019-07-10 メッドシャイン ディスカバリー インコーポレイテッド 抗肺結核症のニトロイミダゾール誘導体
EA201792154A1 (ru) 2015-03-27 2018-02-28 Оцука Фармасьютикал Ко., Лтд. Способ получения 1-(4-гидроксифенил)-4-(4- трифторметоксифенокси)пиперидина или его соли
CN106317072B (zh) * 2015-06-17 2020-03-17 盟科医药技术(上海)有限公司 用于分枝杆菌感染治疗的杂环化合物及其应用
US10851079B2 (en) 2016-02-26 2020-12-01 Otsuka Pharmaceutical Co., Ltd. Piperidine derivative
CN105859628B (zh) * 2016-04-19 2018-08-07 清远职业技术学院 一种抗菌化合物对n咪唑苯甲醛缩邻甲苯胺希夫碱及其制备方法和应用
BR112019001163A2 (pt) * 2016-07-22 2019-04-30 Medshine Discovery Inc. cristal e sal de nitroimidazol e método de fabricação do mesmo
PL3668879T3 (pl) 2017-08-16 2022-02-21 Glaxosmithkline Intellectual Property Development Limited Nowe związki
EA202092952A1 (ru) 2018-06-11 2021-03-22 Оцука Фармасьютикал Ко., Лтд. Содержащая деламанид композиция
CN109705022A (zh) * 2018-12-28 2019-05-03 上海彩迩文生化科技有限公司 一种芳香胺中间体的制备方法
CN112300192B (zh) * 2019-08-02 2023-08-11 南京长澳医药科技有限公司 硝基咪唑类化合物及其制备方法和用途
CN110483549B (zh) * 2019-08-30 2021-03-05 沈阳药科大学 一种硝基咪唑吡喃类抗结核药物的制备方法
CN110615800A (zh) * 2019-10-16 2019-12-27 李丽丽 硝基咪唑类化合物及其制备方法和用途
CN112156088B (zh) * 2020-10-30 2021-08-31 健民药业集团股份有限公司 一种化合物在制备结核分枝杆菌抑制剂中的用途
CN113603706A (zh) * 2021-08-04 2021-11-05 深圳市泰力生物医药有限公司 德拉马尼的晶型、含有该晶型的活性药物和药物组合物
WO2024024938A1 (ja) 2022-07-29 2024-02-01 大塚製薬株式会社 デラマニド含有固体分散体
CN115368252B (zh) * 2022-09-19 2024-01-12 西北农林科技大学 一种4-胺基酚类衍生物及应用
CN116640106B (zh) * 2023-05-11 2024-03-08 郑州大学 一种苯基哌嗪类化合物及其制备方法、应用
CN119059990B (zh) * 2024-11-01 2025-02-07 安徽昊帆生物有限公司 1-氨基甲酸叔丁酯哌嗪的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668127A (en) 1995-06-26 1997-09-16 Pathogenesis Corporation Nitroimidazole antibacterial compounds and methods of use thereof

Also Published As

Publication number Publication date
CY2014041I1 (el) 2016-07-27
US20060094767A1 (en) 2006-05-04
MY139244A (en) 2009-09-30
FR14C0066I1 (OSRAM) 2014-10-17
CA2497569A1 (en) 2004-04-22
JP2004149527A (ja) 2004-05-27
FR14C0066I2 (fr) 2015-05-22
HK1171018A1 (en) 2013-03-15
JP4186065B2 (ja) 2008-11-26
CN101255170A (zh) 2008-09-03
AR086485A2 (es) 2013-12-18
RU2326121C2 (ru) 2008-06-10
WO2004033463A1 (ja) 2004-04-22
AR089950A2 (es) 2014-10-01
CN101172981A (zh) 2008-05-07
AU2003272979A1 (en) 2004-05-04
CA2497569C (en) 2011-05-24
EP1555267A1 (en) 2005-07-20
EP1555267A4 (en) 2010-08-18
PT1555267E (pt) 2013-01-29
PL217919B1 (pl) 2014-09-30
PL404913A1 (pl) 2013-09-30
RU2005114017A (ru) 2006-01-20
AU2003272979B2 (en) 2009-07-23
EP2570418A3 (en) 2013-07-03
TW200420568A (en) 2004-10-16
KR20050061473A (ko) 2005-06-22
AR041198A1 (es) 2005-05-04
TWI347946B (en) 2011-09-01
AR091771A2 (es) 2015-02-25
BRPI0314344B8 (pt) 2021-05-25
LU92517I2 (fr) 2014-10-13
MXPA05003674A (es) 2005-06-08
SI1555267T1 (sl) 2013-05-31
CN102532162A (zh) 2012-07-04
CN102532162B (zh) 2015-05-27
ZA200501033B (en) 2006-06-28
EP2570418A2 (en) 2013-03-20
CY2014041I2 (el) 2016-07-27
UA83200C2 (en) 2008-06-25
BRPI0314344B1 (pt) 2019-11-26
CN1705670A (zh) 2005-12-07
US7262212B2 (en) 2007-08-28
DK1555267T3 (da) 2013-02-11
PL376157A1 (en) 2005-12-27
BE2014C053I2 (OSRAM) 2022-08-30
RU2326121C3 (ru) 2021-09-17
ES2400179T3 (es) 2013-04-08
CY1113578T1 (el) 2016-06-22
HUS1400046I1 (hu) 2017-04-28
BR0314344A (pt) 2005-07-12
KR100723847B1 (ko) 2007-05-31
EP1555267B1 (en) 2013-01-16
CN100366624C (zh) 2008-02-06
HK1085463A1 (zh) 2006-08-25

Similar Documents

Publication Publication Date Title
PL409525A1 (pl) Związek 2,3-dihydro-6-nitroimidazo[2,1-b]oksazolowy
ID29076A (id) Kombinasi senyawa aktif fungisida
MA27899A1 (fr) Compose de glucocorticosteroide specifique a activite anti-inflammatoire
NZ599174A (en) Combinations comprising a fungicidal strain and an azolopyrimidin-7-ylamine
WO2004035569A3 (de) Neue verbindungen mit antibakterieller aktivität
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
UY25677A1 (es) Nuevos agentes bacterianos de isoxazolinona
NO20052787D0 (no) N-alkyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
BR0307924A (pt) N-aril-2-oxazolidinona-5-carboxamidas e seus derivados
ATE353894T1 (de) Acyloxymethylcarbamat-prodrugs von oxazolidinonen
DK1709044T4 (da) Oxazolidinon-quinolon-hybridantibiotika
WO2005012320A3 (en) Novel lincomycin derivatives possessing antimicrobial activity
TW200602295A (en) Organic compounds
NO20062629L (no) Oksazolderivater av tetrackliner
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
WO2004016632A8 (en) Lincomycin derivatives possessing antibacterial activity
AU2005273867A1 (en) Benzothienopyridines for use as inhibitors of Eg5 kinesin
HRP20050611B1 (hr) Kombinacijski lijek
WO2005007665A8 (en) Lincomycin derivatives possessing antibacterial activity
AU2003259159A1 (en) N-aryl-2-oxazolidinones and their derivatives
BRPI0413744A (pt) n-aril-2-ciano-oxazolidinonas e seus derivados
BR0312550A (pt) Derivados de nocatiacina o-derivatizados
MXPA05009243A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados.
RU2002104352A (ru) Штамм бактерий Proteus vulgaris № 25, используемый для изготовления иммунных препаратов
AU2002361049A1 (en) Thiazole derivatives with fungicidal activity